Dr. Reddy's Laboratories Faces Mixed Momentum Amid Sector Performance Discrepancies
Dr. Reddy's Laboratories, a significant entity in the Pharmaceuticals & Biotechnology sector, has seen a recent decline in stock performance, underperforming the sector. With a market capitalization of Rs 1,02,233.30 crore and a P/E ratio notably lower than the industry average, the company exhibits mixed short-term momentum and has lagged behind the Sensex over the past year.
Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has shown notable activity today, underperforming the sector by 0.47%. The stock has experienced a consecutive decline over the past two days, with a total drop of 0.21% during this period. Currently, Dr. Reddy's Laboratories holds a market capitalization of Rs 1,02,233.30 crore, categorizing it as a large-cap company. The stock's price-to-earnings (P/E) ratio stands at 18.16, significantly lower than the industry average of 35.04, indicating a potential valuation discrepancy within the sector.
In terms of moving averages, the stock is performing higher than its 5-day, 20-day, 50-day, and 100-day averages, yet remains below its 200-day moving average, suggesting mixed short-term momentum.
Over the past year, Dr. Reddy's Laboratories has recorded a performance of 5.35%, lagging behind the Sensex, which has gained 11.19%. Year-to-date, the stock has declined by 11.75%, contrasting with the Sensex's positive return of 5.31%. As the pharmaceutical sector continues to evolve, Dr. Reddy's Laboratories remains a key player to watch.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
